CLINICAL_TRIALS
trial_result
· 2013-02-21
Clinical Trial Update: A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients [Phase 2]
Summary
A Phase 2 study comparing four dosing regimens of GW810781 with placebo in HIV-infected patients has completed. The sponsor is GlaxoSmithKline.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: HIV Infections | Phase 2 | Status: COMPLETED